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Immunology has recently witnessed several new developments in understanding the biology of macro-
phages. These exciting developments were the focus of a conference in Marseille, France, in January
2013. This conference is summarized here.If macrophage biologists needed an excuse to take a walk along
breathtaking vistas of the Calanque of Surgiton in the 9th arron-
dissement of Marseille, France (Figure 1), this year they had an
ideal reason. Every other year, the Center of Immunology of
Marseille-Luminy hosts a EuropeanMolecular Biology Organiza-
tion workshop to coincide with the Luminy Advanced Course in
Immunology. In mid-January of this year, the meeting was enti-
tled ‘‘Dr. Jekyll and Mr. Hyde: The Macrophage in Inflammation
and Immunity’’ and was expertly organized by Toby Lawrence,
Michael Sieweke, Giovanna Chimini, Jean-Pierre Gorvel, and
Giacchino Natoli and generously cosponsored by Sanofi.
Indeed, 2013 is a great year in which to take stock of many
recent, key developments in macrophage biology.
The meeting got off to a great start with presentations by
Florent Ginhoux and Frederic Geissmann. They presented their
recent groundbreaking research, which has altered a funda-
mental paradigm that has stood since the late 1960s when the
work of Ralph van Furth led him to develop a model in which tis-
sue macrophages were replenished in homeostasis by circu-
lating blood monocytes. The findings of their laboratories, along
with others, including those of Steffen Jung and Miriam Merad,
provide overwhelming evidence that macrophages in most
organs are seeded prior to birth and that these populations
can proliferate locally throughout life to maintain themselves
independently of adult monocyte input. From their presenta-
tions, it is clear that although there exists strong evidence that
resident macrophages arise independently of adult bloodmono-
cytes, details on the lifecycle and origins of macrophages in the
fetus remain a subject of intense research.
The observation that resident macrophages compose a locally
renewing population raises a number of critical questions, even
as it overturns a long-standing model in the field. These critical
questions center in part on how self-renewal comes about. Other
speakers, including Michael Sieweke and Judith Allen, helped fill
in answers on the mechanisms of macrophage self-renewal.
A few years ago, before the new information emerged as to
how profoundly embryonic macrophages contribute to macro-
phages in adult organs, the Sieweke laboratory identified signals
regulated by transcription factors MafB and Maf, which con-
trol macrophage proliferation. However, considering that the
renewal of many cell types, including most hematopoietic cells,
occurs through tissue-specific stem cells and cycling progenitor
cells, a lingering question has been whether macrophage prolif-
eration is driven by a subset of cells that could be considered
macrophage progenitors in the peripheral population and that
reside alongside mature macrophages. In Marseille, Siewekepresented a series of convincing experiments that culminated
in the conclusion that self-renewal is not obligatorily linked to
pluripotent or multipotent stem cells and that, indeed, cycling
macrophages are fully differentiated, committed macrophages.
The laboratory of Judith Allen has also recently published
exciting work related to the cycling of macrophages. She and
her colleagues have shown that resident macrophages prolifer-
ate in response to parasitic infections, conditions that also cause
these macrophages to polarize toward alternatively activated
macrophages. In Marseille, Allen presented this work and dis-
cussed ongoing work to address the next critical questions: Is
the enhanced rate of macrophage proliferation in response to
infection due to an augmentation of the same signals that pro-
mote self-renewal? Which cytokines regulate self-renewal?
By contrast, expansion of macrophages in some settings
appears to rely on the older paradigm of monocytes as precur-
sors. Adrian Erlebacher highlighted a noninflammatory—even
anti-inflammatory (or immunosuppressive)—state in which the
macrophage pool expands dramatically: pregnancy. In this
case, the increase in macrophages that populate the growing
smooth muscle layer of the uterus is so marked that local macro-
phage proliferation is not sufficient. So where do new macro-
phages come from in this instance? Erlebacher showed that
colony-stimulating factor 1 (CSF-1) drives expression of C-C
motif chemokine 2 (CCL2) in macrophages and, in turn, allows
for the recruitment of new monocytes.
Beyond macrophage origins and control of proliferation, the
meeting stayed true to its title in investigating the ‘‘Dr. Jekyll
and Mr. Hyde’’ orientations of macrophages in different condi-
tions. For example, whereas CCL2-mediated recruitment of
monocyte-derived macrophages is most likely beneficial to the
success of pregnancy, Jeffrey Pollard presented data on the
role of tumor-derived CCL2 in the recruitment of monocytes
that, in this case, undesirably facilitate malignancy. Along with
this example, the meeting discussed many others in which a
given macrophage phenotype is beneficial in one instance but
harmful in another. As discussed extensively at the meeting, it
is likely that the striking plasticity among macrophages and their
overall diversity between organs has evolved to protect the host,
but doing so requires multiple personalities. Often, the outcome
is indeed beneficial, but sometimes the net outcome is failure:
damaged tissue or an escaped pathogen. We learned in
Marseille that the control of plasticity comes in multiple ways.
Adrian Kissenpfennig revealed how suppressors of cytokine
signaling 2 and 3 (SOCS2 and SOCS3, respectively) control
macrophage polarization. He observed that the two residentImmunity 38, April 18, 2013 ª2013 Elsevier Inc. 619
Figure 1. Lalita Ramakrishnan, Left, and Gwen Randolph, Right,
Enjoying the View of the Mediterranean during the EMBO
Conference on Macrophages in January 2013
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peritoneum have different polarization tendencies: the minor
macrophage populationmore readily expresses features associ-
ated with a classically activated, or M1, macrophage, whereas
the major population more readily expresses features of alterna-
tively activated macrophages. SOCS2 and SOCS3 play an
important role in regulating the polarizing balance of these peri-
toneal populations. The presence in organs of distinct resident
macrophage populations that possess a basal bias toward a
particular polarization state is a new concept that complements
the existing paradigm of cue-driven polarization states relevant
to all macrophages. At the transcriptional level, plasticity is sup-
ported by the canonical macrophage-associated transcription
factor CCAAT/enhancer binding protein b (C/EBPb). Achim Leutz
showed that structural changes in C/EBPb define its interac-
tome. Truncated transcripts of C/EBPb function as repressors,
longer forms of C/EBPb function as transcriptional activators,
and posttranslational modifications are also highly influential.
Key examples include data indicating that the mammalian target
of rapamycin (mTOR) regulates osteoclastogenesis through
switching C/EBPb isoforms and distinct posttranslational C/
EBPb modifications that induce differentiation into resident and
inflammatory macrophages, granulocytes, and dendritic cells.
A prime illustration of the challenge that amacrophage faces in
fine tuning its response to the environment could be found in
the presentation of Lalita Ramakrishnan. Her laboratory studies
tuberculosis after Mycobacterium marinum infects a natural
host, the transparent zebrafish, which is ideal for imaging the
course of disease. Her team has been able to use this model, fol-
lowed by analyses in human populations, to identify genotypes
that lead to the progression of tuberculosis at two extremes.
Leukotriene A4 hydrolase (LTA4H) catalyzes the synthesis of
leukotriene B4 (LTB4). Possession of two LTA4H-encoding
alleles that lead to low enzymatic activity allows for the alterna-
tive generation of lipoxins in the 5-lipoxygenase pathway. In
this scenario, inflammation is not robust enough to control infec-620 Immunity 38, April 18, 2013 ª2013 Elsevier Inc.tion. On the other hand, possession of two LTA4H-encoding
alleles that generate more LTB4 leads to a strong inflammatory
response associated with very high levels of tumor necrosis fac-
tor (TNF). This too is detrimental. Individuals carrying one allele
encoding each LTA4H isoform are best able to generate inflam-
mation that is ‘‘just right,’’ neither too little nor toomuch LTB4 and
TNF. In Marseille, Ramakrishnan focused on why too much TNF
is detrimental. TNF created during infection produces reactive
oxygen species that activate a receptor-interacting protein 3
(RIP3)-mediated program of necrosis (necroptosis). Further-
more, TNF induces acid sphingomyelinase, which also contrib-
utes to the induction of macrophage death. This death, which
promotes tuberculosis, can be blocked by simultaneous admin-
istration of drugs to block cyclophilin D and acid sphingomyeli-
nase. Adding to the macrophage’s challenge of containing the
growth on Mycobacterium tuberculosis was David Russell’s
revelation that the bacterium modulates the lipid metabolism of
its host cell to form foamy macrophages containing elevated
cholesterol and fatty acids. Russell went on to demonstrate
that the bacteriummetabolizes host-derived fatty acids as a car-
bon source and to mitigate the impact of toxic intermediates
generated from degradation of cholesterol.
The lesson here is perhaps one that we know but need
constant reminder of: cytokines like TNF can harm the host
and promote disease, but TNF in just the right amount can facil-
itate healing, just as inflammatory monocyte-derived macro-
phages do when they are recruited at the right place and time.
An exciting session entitled ‘‘Regeneration and Healing’’ dis-
cussed an array of different models involving healing and
regeneration by speakers Michal Schwartz, Fabio Rossi, Nadia
Rosenthal, Be´ne´dicte Chazaud, and Luis Alberto Ortiz. These
models ranged from skeletal muscle injury in mouse models to
the regeneration of entire limbs by the axolotl. A remarkably
consistent theme across the various speakers and model sys-
tems in this session was that monocyte recruitment to the site
of injury promotes healing but that the timing must be right. An
absence of mononuclear phagocytes in the axolotl at the time
that a limb is lost leads to complete failure of the limb to regen-
erate, whereas in skeletal-muscle injury in themouse,monocyte-
derived cells appear responsible for keeping pluripotent
mesenchymal stem cells (MSCs) in check, possibly through the
production of TNFa to induce death of MSCs such that they
are kept in check. Reminiscent of the link between mTOR and
polarization, a key theme in regenerating tissuewas the influence
of metabolic input in the control of macrophage polarization, and
different presentations emphasized roles of insulin-like growth
factor 1 (IGF-1) and AMP-activated protein kinase pathways.
The meeting made it evident that understanding macrophage
personality switches—call it Dr. Jekyll, Mr. Hyde, or polariza-
tion—is the frontier in the field and that scientists skilled in areas
ranging from computational to cellular biology are actively un-
covering the mysteries of macrophages. There to guide us and
keep us grounded was Siamon Gordon, who led the way over
the years to framing the key concept of macrophage polariza-
tion. Now, through a heroic effort in proteomics and gene-
expression analysis, he revealed that transglutaminase 2
(TGM2), a universal characteristic of alternatively activated
macrophage, is relevant for mouse and man. His lecture also
reminded us of macrophage phenotypic states that we still
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rophages observed in various infectious and inflammatory
states. He shed some new light on macrophage fusion from a
molecular standpoint. Platelet glycoprotein 4 (CD36) serves to
mediate the engulfment of phagocytic targets like apoptotic cells
when it engages the entire surface of such cargo, but it mediatesmacrophage fusion if it engages the plasma membrane of
another macrophage only on a patch of membrane. But what
is accomplished when macrophages fuse? Clearly, as much as
it was evident in Marseille that advances in macrophage biology
are moving at a faster pace than ever, there remains much to
learn about these most fascinating cells.Immunity 38, April 18, 2013 ª2013 Elsevier Inc. 621
